Advanced search
Publication Cover
OncoImmunology Volume 10, 2021 - Issue 1
Submit an article Journal homepage
3,483
Views
10
CrossRef citations to date
0
Altmetric
Original Research

A phase 1 study of NY-ESO-1 vaccine + anti-CTLA4 antibody Ipilimumab (IPI) in patients with unresectable or metastatic melanoma

Craig L. Slingluffa Department of Surgery/Division of Surgical Oncology, University of Virginia, Charlottesville, VA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6664-4373View further author information
, jrORCID Icon,
Hassane M. Zarourb Division of Medical Oncology, Dept of Medicine and Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USAView further author information
,
Hussein Abdul-Hassan Tawbib Division of Medical Oncology, Dept of Medicine and Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA;c Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TXView further author information
,
John M. Kirkwoodb Division of Medical Oncology, Dept of Medicine and Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USAView further author information
,
Michael A. Postowd Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USAView further author information
,
Philip Friedlandere Department of Medicine, Hematology, and Medical Oncology, Mount Sinai Medical Center, New York, NY, USAView further author information
,
Craig E. Devoef Northwell Health Cancer Institute, Lake Success, NY, USAView further author information
,
Elizabeth M. Gaughang Department of Medicine/Division of Hematology Oncology, University of Virginia, Charlottesville, VA, USAView further author information
,
Ileana S. Mauldina Department of Surgery/Division of Surgical Oncology, University of Virginia, Charlottesville, VA, USAORCID Iconhttps://orcid.org/0000-0002-9318-8342View further author information
ORCID Icon,
Walter C. Olsona Department of Surgery/Division of Surgical Oncology, University of Virginia, Charlottesville, VA, USAView further author information
, jr,
Kelly T. Smitha Department of Surgery/Division of Surgical Oncology, University of Virginia, Charlottesville, VA, USAView further author information
,
Mary J. Macrih Ludwig Institute for Cancer Research, New York, NY, USAView further author information
,
Toni Ricciardih Ludwig Institute for Cancer Research, New York, NY, USAView further author information
,
Aileen Ryanh Ludwig Institute for Cancer Research, New York, NY, USAView further author information
,
Ralph Venhaush Ludwig Institute for Cancer Research, New York, NY, USAView further author information
&
Jedd D. Wolchokd Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA;i Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center;j Parker Institute for Cancer Immunotherapy, San Francisco, California, USAView further author information
 show all
Article: 1898105 | Received 13 Jan 2021, Accepted 26 Feb 2021, Published online: 26 Mar 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.